Search Within

Paul K Paik

Formats
  1. Meeting Abstract (168)
  2. Journal Article (83)
  3. Review (4)
  4. Book Section (1)
Groups
  1. Department of Medicine (256)
  2. Solid Tumor Oncology Division (256)
  3. Thoracic Oncology (256)
  4. GSK Faculty (77)
  5. Department of Pathology and Laboratory Medicine (74)
  6. Human Oncology and Pathogenesis Program (55)

More Groups

People
  1. Mark Kris (55)
  2. Marc Ladanyi (47)
  3. Gregory Riely (42)
  4. Natasha Rekhtman (41)
  5. Charles Rudin (40)
  6. Jamie Chaft (33)

More People

Years
  1. 2025 (6)
  2. 2024 (15)
  3. 2023 (32)
  4. 2022 (39)
  5. 2021 (34)
  6. 2020 (18)

More Years

Publications
  1. Journal of Thoracic Oncology (60)
  2. Journal of Clinical Oncology (49)
  3. Annals of Oncology (34)
  4. Clinical Cancer Research (12)
  5. International Journal of Radiation Oncology, Biology, Physics (11)
  6. Clinical Lung Cancer (6)

More Publications

Publishers
  1. Elsevier Inc. (81)
  2. American Society of Clinical Oncology (56)
  3. Oxford University Press (38)
  4. American Association for Cancer Research (22)
  5. Wiley Blackwell (12)
  6. Nature Publishing Group (11)

More Publishers

Results (256)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized, phase II, placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis
    Meeting Abstract

    Moore, Z. R.; Rimner, A.; Lobaugh, S.; Geyer, A.; Gelblum, D. Y.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Chaft, J. E.; Zauderer, M. G.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Tepotinib in patients with MET exon 14 skipping NSCLC: Efficacy and safety by line of therapy
    Meeting Abstract

    Griesinger, F.; Felip, E.; Smit, E. F.; Veillon, R.; Raskin, J.; Thomas, M.; Conte, P.; Kowalski, D.; Paz-Ares, L.; Garcia Ledo, G.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Tepotinib in Asian patients with advanced NSCLC with MET exon 14 (METex14) skipping
    Meeting Abstract

    Yang, J. C. H.; Ahn, M. J.; Sakai, H.; Morise, M.; Kato, T.; Chen, Y. M.; Han, J. Y.; Yang, J. J.; Zhao, J.; Huang, J.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Safety of MET tyrosine kinase inhibitors in patients with MET exon 14 skipping non-small cell lung cancer: A clinical review
    Review

    Cortot, A.; Le, X.; Smit, E.; Viteri, S.; Kato, T.; Sakai, H.; Park, K.; Camidge, D. R.; Berghoff, K.; Vlassak, S.; more...
    Clinical Lung Cancer (2022)

    Fulltext@MSK | Save
  • Non-small cell lung carcinoma with diffuse co-expression of TTF-1 and p40: Clinicopathologic and genomic features of 13 tumors
    Meeting Abstract

    Savari, O.; Febres-Aldana, C.; Chang, J.; Ventura, K.; Bodd, F.; Paik, P.; Askin, F.; Travis, W.; Rekhtman, N.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Non-small cell lung carcinoma with diffuse co-expression of TTF-1 and p40: Clinicopathologic and genomic features of 13 tumors
    Meeting Abstract

    Savari, O.; Febres-Aldana, C.; Chang, J.; Ventura, K.; Bodd, F.; Paik, P.; Askin, F.; Travis, W.; Rekhtman, N.
    Laboratory Investigation (2022)

    Fulltext@MSK | Save
  • Tepotinib efficacy and safety in patients with MET exon 14 skipping NSCLC: Outcomes in patient subgroups from the VISION study with relevance for clinical practice
    Journal Article

    Le, X.; Sakai, H.; Felip, E.; Veillon, R.; Garassino, M. C.; Raskin, J.; Cortot, A. B.; Viteri, S.; Mazieres, J.; Smit, E. F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeting S100A9–ALDH1A1–retinoic acid signaling to suppress brain relapse in EGFR-mutant lung cancer
    Journal Article

    Biswas, A. K.; Han, S.; Tai, Y.; Ma, W.; Coker, C.; Quinn, S. A.; Shakri, A. R.; Zhong, T. J.; Scholze, H.; Lagos, G. G.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Tepotinib in patients with advanced NSCLC with MET amplification (METamp)
    Meeting Abstract

    Le, X.; O'Hara, R.; Paz-Ares, L.; Van Meerbeeck, J. P.; Viteri Ramirez, S.; Cabrera Galvez, C.; Vincente Baz, D.; Kim, Y. C.; Kang, J. H.; Schumacher, K. M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save